Form4insider filings, from the source

SEC Form 4 · accession 0000921895-17-000407

Enveric Biosciences, Inc. · ENVB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jeffrey E. Eberwein
Director · 10% Owner
Period of report
Jan 30, 2017
Accepted (ET)
Feb 14, 2017 · 7:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F5Jan 30, 2017L143$6.51A82,330IBy: Separately Managed Account
Common StockF1,F5Feb 8, 2017L31$6.51A82,361IBy: Separately Managed Account
Common StockF1,F5Feb 10, 2017P434$6.51A82,795IBy: Separately Managed Account
Common StockF1holding———20,227D
Common StockF1,F2holding———1,666,755IBy: Lone Star Value Investors, LP
9.00% Series A Cumulative Preferred StockF2holding———363,611IBy: Lone Star Value Investors, LP

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses